Courtesy www.news18.com
Pune: The Serum Institute of India (SII) is currently developing another vaccine with US drug-maker Novavax. Serum’s CEO Adar Poonawalla said on Saturday he hopes to launch the new vaccine ‘Covovax’ by June.
Covovax has been found to be 89.3 per cent effective in a UK trial.
“Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” Poonawalla tweeted this afternoon.
Poonawalla’s firm is already making Covishield, developed in partnership with the Oxford University and British-Swedish firm AstraZeneca. Covishield and Bharat Biotech’s Covaxin are being used in the first phase of vaccination process in India.
Also Read: Serum Institute Of India Applies For Study Trial Of Novavax Vaccine
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most…
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
This website uses cookies.
